The performance of investments made by CORUM is not a reliable indicator of future results.
Leiden - Netherlands
This new building is located in Leiden, a conurbation of over 300,000 people in the centre of the Netherlands near Amsterdam, The Hague and Rotterdam. The city is also the science hub of the Netherlands, featuring in particular the "Bio Science Park". This is the most famous science park, where major advances have been made in the medical field, especially in research on the Ebola virus. This 4,900 sq.m asset is located in this biopark dedicated to scientific and medical research, which has attracted over 90 companies specialising in pharmaceuticals and biotechnology. It boasts an occupancy rate nearly 97%.
This property investment generates a net initial yield* of 7.47% (incl. transfer tax and brokerage fees).
EN Missing translation
Batavia Biosciences is specialised in biopharmaceuticals, and manufactures and develops vaccines and antibiotics, but also research material. The company is well renowned for obtaining excellent results in the field of viral vectors. Created in 2009, Batavia Biosciences based its headquarters in Leiden. In 2012, the company launched an American subsidiary and opened an office in Hong Kong in 2015.
Acquisition price (incl. transfer tax and brokerage fees)
Net initial yield*
7,47% (incl. transfer tax and brokerage fees)
* Net initial yield: Annual rent divided by acquisition price including transfer tax and brokerage fees.